GGrantIndex
Sort

40,608 grants matching prostate cancer

Role of Tumor Stem Cells Recurrent Prostate Cancer

$396,862
Gary Smith · Univ Of North Carolina Chapel Hill · P01 · FY2012 · CA

Assays to Identify Prostate Cancer Therapeutics Targeting Antizyme Inhibitor

$396,856
Bruce R Zetter · Boston Children'S Hospital · R01 · FY2019 · CA

Biological and Environmental modifiers of Vitamin D3 and Prostate Cancer Risk

$396,834
Rick Antonius Kittles · University Of Arizona · R01 · FY2015 · MD

Cancer Recurrence: Detection in Administrative Data, Incidence, and Costs

$396,816
Michael James Hassett · Dana-Farber Cancer Inst · R01 · FY2013 · CA

Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa

$396,790
Maria E Arcila · Sloan-Kettering Inst Can Research · U01 · FY2023 · CA

APOBEC proteins as drivers of chromosomal translocations in solid cancers

$396,790
Roberto Chiarle · Boston Children'S Hospital · R01 · FY2022 · CA

Evaluation of the effect of patient-context factors and sample acquisition on the quality and analytical performance of cell-free DNA and circulating tumor cells profiling assays in prostate cancer pa

$396,790
Maria E Arcila · Sloan-Kettering Inst Can Research · U01 · FY2022 · CA

Micro Analytical Immunochemistry

$396,765
Heather Kalish · National Institute Of Biomedical Imaging And Bioengineering · ZIC · FY2025 · EB

Cause and Effect Relationships Between Glycation and the Ancestry Specific Tumor Stroma

$396,725
David Paul Turner · Virginia Commonwealth University · R01 · FY2024 · CA

Regulation of androgen receptor by HER-2 and Ack1 tyrosine kinases

$396,640
Young E Whang · Univ Of North Carolina Chapel Hill · R01 · FY2009 · CA

Erythropoietin Blockade for the Treatment of Cancer

$396,619
C. Anthony Blau · University Of Washington · R01 · FY2008 · CA

Dynamic Metabolic Imaging of Hyperpolarized Substrates

$396,593
Dirk Mayer · Sri International · R01 · FY2009 · EB

Molecular Phenotyping and Image-Guidance for Surgical Treatment of High-Risk Prostate Cancer Using Ultrasmall Silica Nanoparticles

$396,582
Michelle S Bradbury · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA

High-Specificity Imaging Agents for Aggressive Prostate Cancer

$396,577
Martin G Pomper · Johns Hopkins University · R01 · FY2018 · CA

Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics

$396,547
Kimberly Stegmaier · Dana-Farber Cancer Inst · R01 · FY2021 · CA

Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics

$396,547
Kimberly Stegmaier · Dana-Farber Cancer Inst · R01 · FY2018 · CA

Dissecting the Pathogenesis of Ewing Sarcoma with Integrative Genomics

$396,547
Kimberly Stegmaier · Dana-Farber Cancer Inst · R01 · FY2017 · CA

SOUTHWEST ONCOLOGY GROUP

$396,518
Swedish Medical Center, First Hill · U10 · FY2001 · CA

Effects of Insurance Expansions on Cancer Treatment: Recent Policy Changes and Implications for Future Reform

$396,502
Lindsay Marie Sabik · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · HS

Multiphoton Detection of Cancer

$396,482
Warren R Zipfel · Cornell University · R01 · FY2008 · CA

Amoeboid Membrane Dynamics in Prostate Cancer

$396,473
Michael R Freeman · Cedars-Sinai Medical Center · R01 · FY2012 · CA

Solving ascertainment bias in ancient DNA using Ultima Genomics sequencing

$396,455
David Emil Reich · Harvard Medical School · R01 · FY2024 · HG

Rare genitourinary tumors projects

$396,442
Andrea Apolo · Division Of Basic Sciences - Nci · ZIA · FY2022 · CA

High Throughput Microscopy Assays to Identify Inhibitors of Metastasis

$396,325
Sara A Courtneidge · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2008 · CA

Generation and utility of NADPH oxidase inhibitors

$396,325
Sara A Courtneidge · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2010 · CA